Immuneering Corporation (IMRX) Operating margin 2020–2022
Immuneering Corporation (IMRX) operating margin by fiscal year — reported operating income divided by reported revenue.
-16325.8%FY2022 · since FY2020: -739.0% → -16325.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -16325.8% | -14696.6 pp |
| FY2021 | -1629.2% | -890.2 pp |
| FY2020 | -739.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice